Why Some Women Keep GLP-1 Weight Loss Medication Private

Keeping GLP-1 medication private can give some women a sense of control over a sensitive health decision. It can also make care harder to manage when a prescribing clinician lacks the full picture or a patient feels unable to ask for support. The experiences of women described by SELF show how privacy, stigma and medical oversight can collide.

A private decision with practical complications

Caroline, a 34-year-old Montreal resident who asked to be identified by her first name, initially told her boyfriend, mother and close friends when she started Wegovy. Over six months, she lost 30 pounds, going from 130 pounds to what she describes as her “healthy original weight” of 100 pounds. Her loved ones were concerned about the extent of the change and did not want her to lose more.

Caroline says she had tried many approaches to lose weight and felt worn down by the effort. At 5 feet 4 inches, she did not consider herself obese and doubted her regular doctor would prescribe the medication. She instead obtained a prescription through an online service after a phone appointment; she says the prescriber did not know her weight.

She recalls losing weight quickly after starting Wegovy. After six months, she stopped taking it, then gained 10 pounds in a month. She decided to restart and has been using a maintenance-level dose for the past six months, according to her account. This time, she has not told her boyfriend or family. The couple is discussing having children, and she says her boyfriend has seen the medication’s effects and is “done with it.”

Because the medication needs refrigeration, keeping it private takes planning. Caroline stores it at the back of her refrigerator and hides it in hotel or family refrigerators when traveling with her boyfriend. She describes the effort as awkward and stressful.

Why some patients choose not to disclose

Caroline’s experience is not isolated, according to Kia Mitchell, MD, a family and obesity medicine specialist in Jacksonville, Florida. Mitchell says she has seen patients conceal GLP-1 medication from partners to avoid turning treatment into a household argument. For some, deciding who knows about treatment can restore a sense of control after feeling that weight gain was outside their control.

That desire for privacy also appears in an online discussion where women described hiding medication in ordinary containers, including food packaging and bottles. Their explanations ranged from avoiding criticism or lectures to sidestepping questions from family members. One participant said she kept medication from her teenagers because she did not want them to tell her former husband.

Mitchell sees both benefits and costs in this secrecy. Having supportive people around can help someone through a health change, she says, while letting patients decide when and how to discuss medication can feel protective. Ideally, people can trust their partners with sensitive information; in practice, the choice may depend on their relationship and the reactions they expect.

Craig Primack, MD, who leads weight loss care at Hers, says he knows some patients keep medication from partners. He cites concerns about cost, a wish to wait until weight changes are visible, and worries about how treatment might affect a couple’s relationship. He also says some patients fear their partners could react with jealousy as the patient’s appearance changes. Weight stigma may contribute to those concerns, while telemedicine can feel like a less uncomfortable route to care for people who expect bias in a clinic setting.

Secrecy can affect safety and follow-up

There are medical reasons to discuss GLP-1 use with a clinician and, when appropriate, a partner. Mitchell says pregnancy can occur while taking these medications and that she has cared for several patients who became pregnant during treatment. Potential side effects can also be harder to manage if someone feels unable to ask a partner for help. And maintaining a secret can add stress, which Mitchell says may make a weight-related health effort more difficult.

Caroline’s account points to a separate concern: she has not told her regular doctor that she takes Wegovy, although she is worried about possible interactions with the Accutane and Ritalin she also takes. She says she fears damaging her relationship with the doctor by disclosing that she obtained medication elsewhere. With an annual physical approaching, she expects the doctor to notice her weight change.

Caroline says she has used ChatGPT to ask about medication combinations and dosing because she does not feel able to be candid with her doctor. She acknowledges that this is probably not the best option. A chatbot cannot review a person’s medical history or replace a clinician’s judgment, so questions about combining medicines belong in a conversation with a qualified health professional.

Caroline received her prescription through Hers. She says the process involved basic bloodwork and written material, without counseling. Primack says the company’s prescribers ask patients to discuss their care with their regular doctors and ask about mental health, anxiety and stress. He also points to information in the app about sleep and eating patterns. Those steps do not change the value of sharing a complete medication list with the clinician who oversees a patient’s broader care.

Caroline’s experience reflects the tension between wanting to manage weight and feeling uncertain about long-term treatment. She says she does not like the idea of taking medication indefinitely, yet fears regaining weight if she stops. She is also questioning whether her expectations for her body are too demanding. Those concerns are reasons to seek a thoughtful discussion with a prescriber, including about treatment goals, continued use and what to expect if medication changes.

Planning a conversation about treatment

Rachel Goldman, PhD, a clinical psychologist and clinical assistant professor at NYU Grossman School of Medicine whose work includes weight management and disordered eating, suggests that patients start by clarifying their reasons for choosing treatment. Thinking through what the medication means for their health and wellbeing can help them explain the decision without feeling they have to defend it.

Goldman recommends preparing a few phrases in advance and speaking from personal experience. “I” statements can keep the discussion focused on what the patient is experiencing and needs. It may also help to consider what response they hope for: practical support, understanding or simply room to make a health decision without judgment.

Planning for different reactions can make the conversation feel more manageable. A partner may need time to process the news, and an initial response may change as questions and assumptions are addressed. The aim, Goldman says, is not to deliver a perfect explanation, but to create more room for honesty and support over time.

For people taking a GLP-1 medication, privacy is a personal choice, but concealing it from the clinician coordinating their care can leave important questions unanswered. A direct conversation with a doctor or pharmacist can help review other medicines, side effects and pregnancy considerations. For those who want to tell a partner, preparing what they need from that conversation may be a useful first step.

Related:

• Everyone Wants This Unapproved Weight Loss Drug—And Some Have Found a Way to Get It
• How GLP-1s Are Quietly Reshaping Gym Culture
• The Ultimate Grocery List for GLP-1 Users, According to a Dietitian

Get more of SELF’s service journalism delivered to your inbox.